Psychiatric Consultation Protocols for Ketamine Therapy Candidates

Comprehensive psychiatric evaluation is essential for appropriate ketamine therapy candidate selection and treatment optimization. This guide outlines evidence-based consultation protocols for healthcare providers.

Initial Psychiatric Assessment Framework

Comprehensive Diagnostic Evaluation

Clinical Interview Structure:

• Chief complaint and history of present illness
• Detailed psychiatric history including previous treatments
• Substance use history and current status assessment
• Family psychiatric history and genetic risk factors
• Psychosocial stressors and support system evaluation

Validated Assessment Instruments:

• PHQ-9 for depression severity and monitoring
• GAD-7 for anxiety symptom assessment
• MADRS for detailed depression evaluation in clinical settings
• C-SSRS for comprehensive suicidal ideation assessment

Treatment History Documentation

Medication Trial Assessment:

• Detailed documentation of previous antidepressant trials
• Dosing adequacy and duration of each treatment attempt
• Reasons for discontinuation (inefficacy vs tolerability)
• Augmentation strategies attempted and outcomes

Psychotherapy History:

• Types of therapy attempted and duration of treatment
• Current therapeutic relationships and ongoing treatments
• Response to psychotherapy interventions
• Integration plans with ketamine therapy

Risk Assessment and Contraindication Screening

Psychiatric Contraindications

Absolute Contraindications:

• Active psychosis or history of schizophrenia
• Severe personality disorders affecting treatment compliance
• Active substance use disorder with ketamine or dissociatives
• Acute manic episode in bipolar disorder

Relative Contraindications:

• History of ketamine abuse or problematic use
• Severe dissociative disorders
• Active suicidal plan requiring immediate intervention
• Cognitive impairment affecting informed consent capacity

Suicide Risk Assessment

Comprehensive Risk Evaluation:

• Current suicidal ideation intensity and specificity
• Previous suicide attempts and methods used
• Protective factors and reasons for living assessment
• Safety planning and crisis intervention protocols

Risk Stratification:

• Low risk: Passive ideation, strong protective factors
• Moderate risk: Active ideation, some protective factors
• High risk: Plan/intent, limited protective factors, requires enhanced safety measures

Treatment Planning and Goal Setting

Individualized Treatment Plans

Therapeutic Objectives:

• Specific, measurable treatment goals and timelines
• Functional improvement targets (work, relationships, self-care)
• Quality of life enhancement priorities
• Integration with ongoing mental health treatments

Treatment Protocol Selection:

• IV vs sublingual administration considerations
• Dosing frequency and maintenance planning
• Integration with psychotherapy and other interventions
• Monitoring and adjustment protocols

Informed Consent Process

Comprehensive Patient Education:

• Mechanism of action and expected effects explanation
• Potential benefits and realistic outcome expectations
• Side effects profile and management strategies
• Alternative treatment options and rationale for ketamine selection

Consent Documentation:

• Written informed consent with detailed risk discussion
• Patient understanding verification and documentation
• Ongoing consent process for treatment adjustments
• Right to discontinue treatment at any time

Conclusion

Comprehensive psychiatric consultation protocols ensure appropriate patient selection, optimize treatment outcomes, and maintain safety standards in ketamine therapy programs. These evidence-based approaches support both individual patient care and overall program quality.

Healthcare providers implementing these consultation protocols will be better positioned to identify suitable candidates, manage complex cases, and achieve optimal therapeutic outcomes while maintaining the highest safety standards.